Gray Matters from Epilepsia

2022 Gray Matters

May 2022

  • Letter: The need for a pragmatic seizure classification in clinical trials

January 2022

  • Letter: Clinical predictors of response to adjunctive brivaracetam: Insights from real-world data
  • Letter: The EpiPick algorithm to select appropriate antiseizure medications in patients with epilepsy: Validation studies and updates

2021 Gray Matters

December 2021

  • Letter: Is the crystal ball broken? Another external validation of the post-withdrawal seizure-relapse prediction model
    • Response: Brightening the crystal ball: A constructive reappraisal of the postwithdrawal seizure relapse prediction model
  • Letter: Vertical hemispherotomy for drug-resistant epilepsy: Toward confirmation of the HOPS study

November 2021

  • Letter: SUDEP-7 Inventory: Validation in a retrospective cohort study
    • Response: SUDEP-7 Inventory: Validation in a retrospective cohort study
  • Letter: The true prevalence of psychogenic nonepileptic seizures is much higher than this
    • Response: The true prevalence of psychogenic nonepileptic seizures is much higher than this

October 2021

  • Letter: Low statistical power in a study predicting seizure outcome
    • Response: “Low statistical power in a study predicting seizure outcome”
  • Letter: SUDEP-3: probable improvement in risk stratification for sudden death in epilepsy

May 2021

  • Invitation to participate in a prospective case-control study of sudden unexpected death in epilepsy
  • Letter: The unclear interhemispheric modulation of mood: A response to Doherty et al. on predicting mood decline following temporal lobe surgery in adults
    • Response: Predicting mood decline following temporal lobe surgery in adults
  • Echocardiography in epilepsy: A tool to be explored
    • Response: Let us not miss the forest for the trees: Reply to "Echocardiography in epilepsy: A tool to be explored"
  • Usefulness of the postkainate spontaneous recurrent seizure model for screening for antiseizure and neuroprotective effects
    • Response: Usefulness of the postkainate spontaneous recurrent seizure model for screening for antiseizure and neuroprotective effects
  • Announcements of future congresses and courses

April 2021

  • Impact of carbamazepine and lacosamide on serum lipid levels

March 2021

  • Announcements of future congresses and courses

February 2021

  • Letter: Toward the optimal surgical treatment of hypothalamic hamartoma
  • Announcements